The story of Viagra presents a challenging picture for shareholders. While the initial introduction generated substantial gains, the lapse of its exclusive rights opened the avenue to off-brand versions, dramatically https://doctorbookmark.com/story21699215/the-copyright-and-pharma-a-precarious-bet